Ambu A/S | AMBUB - Ebitda

Aktienkurs
65.10
Täglich Wechseln
-1.05 -1.59%
Monatlich
-4.41%
Jährlich
-44.12%
Q2 Prognose
61.91




Ebitda Veränderung Datum
Ambu A/S DKK 261M 17M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Brookdale Senior Living USD 105.56M 5.51M 2025-12
Cencora USD 1.2B 42.41M 2025-12
Coloplast 2.39B 132M 2025-09
Encompass Health USD 335.6M 35.5M 2025-12
Enovis USD 111.9M 17.1M 2025-12
GE HealthCare Technologies USD 1.1B 187M 2025-12
OPKO Health USD 75.53M 144.7M 2025-09
Pediatrix Medical Group USD 65.84M 21.47M 2025-12
Veradigm USD 38.81M 29.61M 2022-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12